Hormone therapy: A 3-part CME series

Long-term use of hormone therapy, quality of life, and statins
(Part 3 of 3)

Program Chair, Principal Scientist and Medical Director, Jackson Hole Center for Preventive Medicine, Jackson Hole, Wyoming; Adjunct Scholar in Epidemiology, University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics, Philadelphia, Pennsylvania; Professor of Family and Preventive Medicine, University of California, San Diego (retired)

Professor of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York

Clinical Professor of Obstetrics and Gynecology, George Washington University, President and Medical Director, James A. Simon, MD, PC, Women’s Health & Research Consultants^®, Washington, DC

ObGyns frequently address patient concerns about the safety of hormone therapy (HT) in managing their postmenopausal symptoms. In this case-based CME newsletter series, Robert D. Langer, MD, MPH, Rogerio A. Lobo, MD, and James A. Simon, MD, CCD, NCMP, FACOG, discuss issues in HT, including counseling and managing patients who are concerned about the safety of HT, resolving progestogen-related side effects, and long-term use of HT, quality of life, and statins. They also provide insights for developing treatment plans tailored to the individual patient.

Read the complete CME information
Click here for the CME test